Using multi-omics data across 33 different cancer types and advanced analytical techniques such as Gene Set Enrichment Analysis (GSEA) and Gene Set Variation Analysis (GSVA), we clarified TUBA1B’s role in tumor progression and its association with immune pathways (Ye et al., 2021; Liu and Tang, 2023b). This evidence concerns the gene TUBA1B and neoplasm.